Immuron (IMRN) Receivables (2016 - 2025)
Immuron (IMRN) posted quarterly Receivables of $42571.7 for Q3 2025, up 206.81% year-on-year from $13875.7 in Q3 2024, and down 96.91% on a QoQ basis from $1.4 million in Q2 2025.
Immuron (IMRN) Receivables (2016 - 2025) Analysis & Trends
Immuron (IMRN) has reported Receivables for 10 consecutive years, with $42571.7 the latest figure, recorded in Q3 2025.
- Quarterly Receivables rose 206.81% year-over-year to $42571.7 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $42571.7 (up 206.81% YoY) and the FY2025 annual result came in at $42571.7, up 206.81% from the prior year.
- Receivables eased to $42571.7 in Q3 2025 per IMRN's latest filing, from $1.4 million in the prior quarter.
- Over the last five years, Receivables for IMRN reached as high as $1.6 million in Q4 2024 and fell as low as $4174.2 in Q3 2023.
- A 5-year average of $617504.8 and a median of $468153.5 in 2022 frame the typical range for Receivables.
- Annual changes were most pronounced in 2021 — Receivables surged 24794.77% — and 2023, when it slumped 99.11%.
- Year by year, Receivables stood at $236378.3 in 2021, then jumped by 98.05% to $468153.5 in 2022, then jumped by 158.32% to $1.2 million in 2023, then jumped by 32.79% to $1.6 million in 2024, then tumbled by 97.35% to $42571.7 in 2025.
- According to Business Quant data, Receivables over the past three periods registered $42571.7, $1.4 million, and $1.6 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | 42,571.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 42,571.70 |
| Jun 30, 2025 | 1.38 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 9, 2024 | 13,875.73 |
| Jun 30, 2024 | 999,712.58 |
| Dec 31, 2023 | 1.21 Mn |
| Sep 28, 2023 | 294,792.30 |
| Aug 30, 2023 | 4,174.20 |
| Jun 30, 2023 | 1.43 Mn |
| Dec 31, 2022 | 468,153.51 |
| Aug 31, 2022 | 468,153.51 |
| Jun 30, 2022 | 468,153.51 |
| Dec 31, 2021 | 236,378.34 |
| Jun 30, 2021 | 23,801.00 |
| Dec 31, 2020 | 949.51 |
| Sep 1, 2020 | 327,689.00 |
| Jun 30, 2020 | 231,422.06 |
| Dec 31, 2019 | 3,276.89 |
| Jun 30, 2019 | 1.07 Mn |
| Dec 31, 2018 | 1.68 Mn |